NCT07121114View on ClinicalTrials.gov

CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India

CompletedOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

July 9, 2025

Study Completion Date

July 9, 2025

Conditions

Type 2 Diabetes Mellitus

Interventions

OTHER

No treatment given

No treatment given

Trial Locations (1)

560045

Novo Nordisk Investigational Site, Bangalore

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY